HLA-G is an inhibitory checkpoint molecule, which is highly expressed in gynecological cancers, such as cervical cancer (3, 4, 7–10), ovarian cancer (20), breast cancer (21, 22), and endometrial cancer (23). Here, HLA-G is linked to cervical cancer.